Switch theme
Sign up to access all valuation multiples
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
2001
349
LTM Revenue $209M
LTM EBITDA $132M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
GNI Group has a last 12-month revenue (LTM) of $209M and a last 12-month EBITDA of $132M.
In the most recent fiscal year, GNI Group achieved revenue of $162M and an EBITDA of $21.3M.
GNI Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See GNI Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $209M | XXX | $162M | XXX | XXX | XXX |
| Gross Profit | $209M | XXX | $124M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 76% | XXX | XXX | XXX |
| EBITDA | $132M | XXX | $21.3M | XXX | XXX | XXX |
| EBITDA Margin | 63% | XXX | 13% | XXX | XXX | XXX |
| EBIT | $72.8M | XXX | $9.6M | XXX | XXX | XXX |
| EBIT Margin | 35% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $33.9M | XXX | $7.5M | XXX | XXX | XXX |
| Net Margin | 16% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, GNI Group's stock price is JPY 4290 (or $29).
GNI Group has current market cap of JPY 215B (or $1.5B), and EV of JPY 205B (or $1.4B).
See GNI Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.5B | XXX | XXX | XXX | XXX | $0.69 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, GNI Group has market cap of $1.5B and EV of $1.4B.
GNI Group's trades at 8.7x EV/Revenue multiple, and 66.0x EV/EBITDA.
Equity research analysts estimate GNI Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
GNI Group has a P/E ratio of 43.6x.
See valuation multiples for GNI Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 6.7x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | 66.0x | XXX | XXX | XXX |
| EV/EBIT | 19.3x | XXX | 146.1x | XXX | XXX | XXX |
| EV/Gross Profit | 6.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 43.6x | XXX | 196.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -43.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGNI Group's last 12 month revenue growth is 37%
GNI Group's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.3M for the same period.
GNI Group's rule of 40 is 92% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
GNI Group's rule of X is 154% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for GNI Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 37% | XXX | 36% | XXX | XXX | XXX |
| EBITDA Margin | 63% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | -14% | XXX | 29% | XXX | XXX | XXX |
| Rule of 40 | 92% | XXX | 50% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 154% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 70% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
GNI Group acquired XXX companies to date.
Last acquisition by GNI Group was XXXXXXXX, XXXXX XXXXX XXXXXX . GNI Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was GNI Group founded? | GNI Group was founded in 2001. |
| Where is GNI Group headquartered? | GNI Group is headquartered in Japan. |
| How many employees does GNI Group have? | As of today, GNI Group has 349 employees. |
| Who is the CEO of GNI Group? | GNI Group's CEO is Dr. Ying Luo, PhD. |
| Is GNI Group publicy listed? | Yes, GNI Group is a public company listed on TKS. |
| What is the stock symbol of GNI Group? | GNI Group trades under 2160 ticker. |
| When did GNI Group go public? | GNI Group went public in 2007. |
| Who are competitors of GNI Group? | Similar companies to GNI Group include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of GNI Group? | GNI Group's current market cap is $1.5B |
| What is the current revenue of GNI Group? | GNI Group's last 12 months revenue is $209M. |
| What is the current revenue growth of GNI Group? | GNI Group revenue growth (NTM/LTM) is 37%. |
| What is the current EV/Revenue multiple of GNI Group? | Current revenue multiple of GNI Group is 6.7x. |
| Is GNI Group profitable? | Yes, GNI Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of GNI Group? | GNI Group's last 12 months EBITDA is $132M. |
| What is GNI Group's EBITDA margin? | GNI Group's last 12 months EBITDA margin is 63%. |
| What is the current EV/EBITDA multiple of GNI Group? | Current EBITDA multiple of GNI Group is 10.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
